These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 31836883)

  • 1. Losartan protects against intermittent hypoxia-induced peritubular capillary loss by modulating the renal renin-angiotensin system and angiogenesis factors.
    Wu J; Chu Y; Jiang Z; Yu Q
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):38-48. PubMed ID: 31836883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telmisartan protects chronic intermittent hypoxic mice via modulating cardiac renin-angiotensin system activity.
    Wang W; Song A; Zeng Y; Chen X; Zhang Y; Shi Y; Lin Y; Luo W
    BMC Cardiovasc Disord; 2018 Jul; 18(1):133. PubMed ID: 29969996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central losartan attenuates increases in arterial pressure and expression of FosB/ΔFosB along the autonomic axis associated with chronic intermittent hypoxia.
    Knight WD; Saxena A; Shell B; Nedungadi TP; Mifflin SW; Cunningham JT
    Am J Physiol Regul Integr Comp Physiol; 2013 Nov; 305(9):R1051-8. PubMed ID: 24026072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan attenuates aortic endothelial apoptosis induced by chronic intermittent hypoxia partly via the phospholipase C pathway.
    Ren J; Liu W; Deng Y; Li GC; Pan YY; Xie S; Jin M; Liu HG
    Sleep Breath; 2017 Sep; 21(3):679-689. PubMed ID: 28190165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor.
    Marcus NJ; Li YL; Bird CE; Schultz HD; Morgan BJ
    Respir Physiol Neurobiol; 2010 Apr; 171(1):36-45. PubMed ID: 20153844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ARB treatment prevents the decrease in endothelial progenitor cells and the loss of renal microvasculature in remnant kidney.
    Yu Y; Wang Y; Zhou LN; Zheng F
    Am J Nephrol; 2011; 33(6):550-7. PubMed ID: 21613782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
    Sakuta T; Morita Y; Satoh M; Fox DA; Kashihara N
    Arthritis Rheum; 2010 May; 62(5):1319-28. PubMed ID: 20213806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors.
    Takazawa Y; Maeshima Y; Kitayama H; Yamamoto Y; Kawachi H; Shimizu F; Matsui H; Sugiyama H; Yamasaki Y; Makino H
    Kidney Int; 2005 Aug; 68(2):704-22. PubMed ID: 16014048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
    Kosaka T; Miyajima A; Shirotake S; Kikuchi E; Hasegawa M; Mikami S; Oya M
    Prostate; 2010 Feb; 70(2):162-9. PubMed ID: 19760626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin angiotensin system blockade ameliorates lead nephropathy.
    Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
    Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CB1 receptor antagonist rimonabant protects against chronic intermittent hypoxia-induced renal injury in rats.
    Zhao L; Liu T; Dou ZJ; Wang MT; Hu ZX; Wang B
    BMC Nephrol; 2021 Apr; 22(1):153. PubMed ID: 33902473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone suppresses peritubular capillary loss and prevents deoxycorticosterone acetate/salt-induced tubulointerstitial fibrosis.
    Iwazu Y; Muto S; Fujisawa G; Nakazawa E; Okada K; Ishibashi S; Kusano E
    Hypertension; 2008 Mar; 51(3):749-54. PubMed ID: 18250361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of angiotensin-(1-7) administrated with an angiotensin-receptor blocker in a rat model of chronic kidney disease.
    Xu C; Ding W; Zhang M; Gu Y
    Nephrology (Carlton); 2013 Dec; 18(12):761-9. PubMed ID: 23901805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells.
    Zhou L; Xue H; Yuan P; Ni J; Yu C; Huang Y; Lu LM
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):e152-7. PubMed ID: 20590668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin 2 type 1 receptor blockade different affects postishemic kidney injury in normotensive and hypertensive rats.
    Miloradović Z; Ivanov M; Jovović Đ; Karanović D; Vajić UJ; Marković-Lipkovski J; Mihailović-Stanojević N; Milanović JG
    J Physiol Biochem; 2016 Dec; 72(4):813-820. PubMed ID: 27534651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension.
    Rincón J; Correia D; Arcaya JL; Finol E; Fernández A; Pérez M; Yaguas K; Talavera E; Chávez M; Summer R; Romero F
    Life Sci; 2015 Mar; 124():81-90. PubMed ID: 25623850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor-4 deficiency alleviates chronic intermittent hypoxia-induced renal injury, inflammation, and fibrosis.
    Zhang Y; Su X; Zou F; Xu T; Pan P; Hu C
    Sleep Breath; 2019 Jun; 23(2):503-513. PubMed ID: 30099700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
    Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
    J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular factors of angiogenesis in renal tissue of patients with chronic glomerulonephritis: association with nephrosclerosis and anemia].
    Shvetsov MIu; Ivanov AA; Kuznetsova AV; Popova OP; Rameeva AS
    Ter Arkh; 2009; 81(8):14-9. PubMed ID: 19799194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.